U.S. SARS-CoV-2 Seroprevalence High Based on Blood Donations
By December 2021, combined seroprevalence from infection or vaccination estimated to be 94.7 percent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.